parp inhibitor

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030

  Roots Analysis is pleased to announce the publication of its recent study, titled, “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”.   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of such […]

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030 Read More »

The synthetic lethality-based drugs and targets market

Roots Analysis is pleased to announce the publication of its recent study, titled, “Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways”.   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of such compact

The synthetic lethality-based drugs and targets market Read More »